Benzinga's Top Initiations
August 01, 2014 at 09:22 AM EDT
Analysts at Roth Capital initiated coverage on Alcobra Pharma (NASDAQ: ADHD) with a Buy rating. The target price for Alcobra Pharma is ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.